Steady state analysis (WinNonlin) [Software]

posted by Helmut Homepage – Vienna, Austria, 2009-12-30 15:45 (5649 d 20:26 ago) – Posting: # 4539
Views: 8,162

Dear Naresh!

❝ I have to perform Steady state analysis in WinNonlin, but I am not sure

❝ about the method which I supposed to be used will give correct results or

❝ not,


Any specific questions? Which version of WinNonlin are you using (WinNonlin 5.x, Phoenix 6.x)?
I guess you have read the User's Guide (WNL v5.2.1 page 172, Phoenix 6.0 page 280, Phoenix 6.1 page 277).

❝ If any one can provide data with results then I can crosscheck with my

❝ method.


Critical are only time deviations of samples scheduled at t=tau. WinNonlin estimates AUC_TAU based on lambda_z; therefore if the last sampling time point deviates from tau you should get an AUC_TAU # AUClast.
Open WinNonlin's 'Exp1.pwo':
in 'Dosing Regimen' check 'Steady state', Dose 1, Time of Last Dose 0, Tau 24
in 'Model Options' > 'NCA Settings' > 'Calculation Method' > Linear Trapezoidal (Linear/Log Interpolation)
You should get
  Lambda_z 0.0646
  AUClast 69.7739
  AUC_TAU 69.7739
(AUCtau=AUClast, because tlast=tau)
Change the last time point in 'Exp1.pwo' from 24 h to 23.5 h > in 'NCA Workbook' > right click > Refresh
  Lambda_z 0.0677
  AUClast 68.8564
  AUC_TAU 69.4879
(AUCtau>AUClast, because tlast<tau)
Change the last time point in 'Exp1.pwo' from 24 h to 24.5 h > in'NCA Workbook' > right click > Refresh
  Lambda_z 0.0596
  AUClast 70.7462
  AUC_TAU 70.0202
(AUCtau<AUClast, because tlast>tau)

Does this example answer your question?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
38 visitors (0 registered, 38 guests [including 8 identified bots]).
Forum time: 13:12 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5